In my career, I focus on three key pillars:1) Driving Innovation: Led the development and approval of new modalities and long-acting technologies in ophthalmology and secured FDA/EMA approval for a long-acting injectable drug for prostate cancer.2) Leadership and Collaboration: Expert in cross-functional collaboration within CMC drug development, spanning pre-clinical, clinical, regulatory, quality, manufacturing, partnering, and life-cycle management.3) Global Experience: Cultivated diverse expertise through work in Switzerland, Denmark, Nth Ireland and France, continuously learning from varied cultures and ways of working.Passionate about driving impactful innovation and fostering collaboration for positive change. Let's connect and explore opportunities.